title: [Practical comments on the use of immunoglobulins].
abstract: The paper contains basic information relating to treatment with immunoglobulin. Presented indications for their use, among others: primary immunodeficiency, Kawasaki disease, Guillain-Barre syndrome, chronic lymphocytic leukemia, primary thrombocytopenia. The factors to consider when choosing a preparation: the content of IgG, IgA, method of administration (intravenous or subcutaneous). The most frequent side effects, depending on the organ localization. Presented at risk (obesity, diabetes, renal failure, hypovolemia) in which these symptoms may occur especially frequently, which should be taken into account in the conduct of therapy (adequate hydration, low-dose, slow infusion).
authors.affiliation: III Katedra i Klinika Pediatrii, Immunologii i Reumatologii Wieku Rozwojowego, Akademia Medyczna we Wrocławiu. alusz1@poczta.onet.pl
authors.forename: Aleksandra
authors.initials: A
authors.lastname: Lewandowicz-Uszyńska
authors.forename: Jerzy
authors.initials: J
authors.lastname: Swierkot
mesh_terms: D000368:Aged; D003663:Decision Trees; D020275:Guillain-Barre Syndrome / Q000188:drug therapy; D006801:Humans; D007136:Immunoglobulins / Q000009:adverse effects* / Q000627:therapeutic use*; D016756:Immunoglobulins, Intravenous / Q000009:adverse effects / Q000627:therapeutic use; D007153:Immunologic Deficiency Syndromes / Q000188:drug therapy; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy; D009080:Mucocutaneous Lymph Node Syndrome / Q000188:drug therapy; D012307:Risk Factors; D013921:Thrombocytopenia / Q000188:drug therapy
chemical_list: D007136:Immunoglobulins; D016756:Immunoglobulins, Intravenous